SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 83 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2013. The put-call ratio across all filers is 0.12 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $12,000 | -78.9% | 43,900 | -81.4% | 0.00% | – |
| Q1 2016 | $57,000 | -61.0% | 235,700 | -42.8% | 0.00% | – |
| Q4 2015 | $146,000 | -74.0% | 411,961 | +27.7% | 0.00% | -100.0% |
| Q3 2015 | $562,000 | -15.0% | 322,497 | +8.8% | 0.00% | 0.0% |
| Q2 2015 | $661,000 | +2.6% | 296,382 | -10.6% | 0.00% | 0.0% |
| Q1 2015 | $644,000 | +25.0% | 331,670 | +70.7% | 0.00% | 0.0% |
| Q4 2014 | $515,000 | -9.8% | 194,260 | +2.4% | 0.00% | 0.0% |
| Q3 2014 | $571,000 | -25.0% | 189,685 | +2.0% | 0.00% | 0.0% |
| Q2 2014 | $761,000 | -5.7% | 186,023 | -0.6% | 0.00% | 0.0% |
| Q1 2014 | $807,000 | +14.0% | 187,175 | +38.7% | 0.00% | 0.0% |
| Q4 2013 | $708,000 | +6.0% | 134,996 | +29.5% | 0.00% | 0.0% |
| Q3 2013 | $668,000 | +34.1% | 104,268 | +4.8% | 0.00% | 0.0% |
| Q2 2013 | $498,000 | – | 99,515 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 28,639,349 | $123,436,000 | 94.21% |
| Verity Asset Management, Inc. | 103,021 | $456,000 | 0.47% |
| NBW CAPITAL LLC | 242,153 | $1,044,000 | 0.27% |
| Old West Investment Management, LLC | 69,997 | $301,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 196,639 | $848,000 | 0.12% |
| SOPHROSYNE CAPITAL LLC | 25,700 | $111,000 | 0.10% |
| Cutler Capital Management, LLC | 45,000 | $194,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,700 | $50,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 66,397 | $286,000 | 0.06% |
| Roundview Capital LLC | 21,100 | $91,000 | 0.04% |